Ilce Mara Syllos Cólus

11PUBLICATIONS
35CO-AUTHORS
Biologically active moleculesCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 13, 2026
Therapeutic potential of Brazilian medicinal plants and their metabolites.

Juliana Mara Serpeloni, Fabio Vieira Dos Santos, Katiuska Tuttis

|Mar 26, 2026
Genetic variants in 8-oxoguanine DNA glycosylase 1 (OGG1) and X-ray repair cross-complementing protein 1 (XRCC1) and non-genetic factors are associated with bladder cancer susceptibility and prognosis in a Brazilian population.

Milene Roldão de Souza Rodrigues, Isabely Mayara da Silva, Beatriz Geovana Leite Vacario

|Dec 14, 2023
Effects of docetaxel on metastatic prostate (DU-145) carcinoma cells cultured as 2D monolayers and 3D multicellular tumor spheroids.

Andressa Yuri Fujiike, Larissa Cristina Bastos de Oliveira, Diego Luis Ribeiro

|Aug 03, 2022
The potential of cell-free and exosomal microRNAs as biomarkers in liquid biopsy in patients with prostate cancer.

Monyse de Nóbrega, Mariana Bisarro Dos Reis, Érica Romão Pereira

|Jun 16, 2022
Polymorphic variants of the CASP3, CASP9, BCL-2 and NKX3-1 genes as candidate markers for prostate cancer susceptibility and poor prognosis.

Milene Roldão de Souza, Marilesia Ferreira de Souza, Monyse de Nóbrega

|May 28, 2022
The Antitumoral/Antimetastatic Action of the Flavonoid Brachydin A in Metastatic Prostate Tumor Spheroids In Vitro Is Mediated by (Parthanatos) PARP-Related Cell Death.

Diego Luis Ribeiro, Katiuska Tuttis, Larissa Cristina Bastos de Oliveira

Pageof 2

Frequent Collaborators

6 joint publications

Juliana Mara Serpeloni

3 joint publications

Larissa Cristina Bastos de Oliveira

3 joint publications

Paulo Emilio Fuganti

3 joint publications

Diego Luis Ribeiro